11 – 20 of 93
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Detection of Copy Number Aberration and Tumor Fraction in Archival Cervical Specimens from Ovarian Cancer Patients using Shallow Whole Genome Sequencing.
2021)(
- Contribution to conference › Poster
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
(
- Contribution to journal › Article
-
Mark
Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer
(
- Contribution to journal › Article
-
Mark
Homologous recombination repair mechanisms in serous endometrial cancer
(
- Contribution to journal › Article
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
(
- Contribution to journal › Article
-
Mark
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
(
- Contribution to journal › Article
-
Mark
Common Susceptibility Loci for Male Breast Cancer
(
- Contribution to journal › Article